Internationale Innovative Ophthalmochirurgie GbR (I.I.O.)

The medical center is at the forefront of ophthalmology research, focusing on innovative treatments for complex eye conditions. One of the key areas of study is the management of macular edema due to central retinal vein occlusion, where the center is exploring the potential of combining ranibizumab injections with early targeted peripheral laser photocoagulation to potentially reduce or eliminate the need for ongoing injections.

• Macular Edema Treatment
• Central Retinal Vein Occlusion
• Ranibizumab and Laser Photocoagulation

This research aims to enhance patient outcomes by potentially reducing treatment frequency, thereby improving quality of life for those affected by these conditions.

In the realm of pediatric ophthalmology, the center is conducting pioneering research on the progression of myopia in children. A significant study is underway to determine the most effective dose of low-dose atropine eye drops to slow down the progression of myopia, a condition that is increasingly prevalent among children in Europe.

• Myopia Progression in Children
• Atropine Eye Drops
• Dose-Finding Studies

By identifying the optimal dosage, the center aims to provide a safe and effective treatment option that can be widely adopted to manage myopia in pediatric populations.